4//SEC Filing
Hatzis-Schoch Brent 4
Accession 0000899243-21-015666
CIK 0001701541other
Filed
Apr 12, 8:00 PM ET
Accepted
Apr 13, 8:45 PM ET
Size
8.8 KB
Accession
0000899243-21-015666
Insider Transaction Report
Form 4
Hatzis-Schoch Brent
SEE REMARKS
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2021-04-12−179,915→ 164,552 totalExercise: $3.20Exp: 2029-06-11→ Common Stock (4,078 underlying) - Sale
Common Stock
2021-04-12$25.00/sh−4,078$101,950→ 8,400 total - Exercise/Conversion
Common Stock
2021-04-12$3.20/sh+4,078$13,050→ 12,478 total
Footnotes (2)
- [F1]Shares sold pursuant to a pre-established 10b5-1 trading plan effective as of June 12, 2020.
- [F2]25% of the shares subject to this option vested and became exercisable on May 22, 2020, with the remainder vesting in 36 equal monthly installments thereafter.
Documents
Issuer
Black Diamond Therapeutics, Inc.
CIK 0001701541
Entity typeother
Related Parties
1- filerCIK 0001637054
Filing Metadata
- Form type
- 4
- Filed
- Apr 12, 8:00 PM ET
- Accepted
- Apr 13, 8:45 PM ET
- Size
- 8.8 KB